300+ investors in your industry, stage, and region Get
Any industry
EdTech
Venture Capital
Video Games
Hospitality
Restaurants
Crowdfunding
Financial Services
Photography
Cryptocurrency
Digital Media
Big Data
Email
Artificial Intelligence
Clean Energy
Non Profit
Social Impact
Energy
SaaS
Google
CleanTech
Consumer
Health Care
Enterprise Software
Local
Travel
Platforms
InsurTech
Construction
Oil and Gas
Mobile
Retail
Film
Payments
Marketplace
Fitness
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Medical Device
Wellness
Education
Sports
Legal
Automotive
eSports
Biotechnology
Renewable Energy
Software
Facebook
Blockchain
Theatre
Medical
Web3
Recruiting
Beauty
Fashion
Infrastructure
Celebrity
Social
Food and Beverage
Life Science
Publishing
Wine and Spirits
Mobile Apps
Real Estate
Sporting Goods
Music
Art
Finance
Manufacturing
FinTech
Social Media
Franchise
Internet
Mobile Advertising
Android
Impact
Proptech
Hardware
Transportation
Biotech
Sustainability
Enterprise
Community
Cannabis
Media (Entertainment)
LGBT
Climate
Any country
Afghanistan
Greece
Thailand
United Arab Emirates
Andorra
Dominica
Japan
Brazil
Singapore
Burkina Faso
Africa
LATAM
Egypt
United Kingdom
Faroe Islands
South Korea
Hong Kong
Benin
Nigeria
Togo
Croatia
Gibraltar
Guinea
Kyrgyzstan
Norway
Haiti
Sudan
Malawi
Isle of Man
Iran
Madagascar
Lesotho
Russian Federation
Turkey
Liberia
Nepal
Pakistan
Mexico
Tajikistan
Sweden
Zambia
Romania
Oceania
Argentina
Tunisia
Oman
Taiwan
Zimbabwe
Puerto Rico
Poland
Guernsey
Cameroon
Colombia
Armenia
China
Costa Rica
Côte d'Ivoire
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Morocco
Australia
Jamaica
Sri Lanka
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Uruguay
Moldova
New Zealand
Seychelles
Botswana
Paraguay
France
South Africa
Denmark
Georgia
Ghana
Iraq
Philippines
Portugal
Sierra Leone
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Bangladesh
Cyprus
Barbados
Qatar
Belgium
Austria
Ethiopia
Azerbaijan
Jordan
Ecuador
Bahamas
Bahrain
Bulgaria
Jersey
Estonia
Bolivia
Belize
Algeria
Belarus
Hungary
Finland
Grenada
Israel
Honduras
Lithuania
Italy
Cambodia
Iceland
Liechtenstein
Lebanon
Mongolia
Slovenia
Peru
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Finchley Healthcare Ventures, VC Fund

Finchley Healthcare Ventures

VC Fund

Finchley Healthcare Ventures is an investment firm invest in venture capital funds specializing in life sciences, leveraging their expertise and network to access a diverse range of investment opportunities.

Total investments:
4
Last investment:
Lead investor:
0%

Last updated:

Industries Finchley Healthcare Ventures invests in

BiotechnologyBiopharmaHealth CareLife ScienceMedical

Stages Finchley Healthcare Ventures invests in

Series BSeedSeries A

Countries Finchley Healthcare Ventures invests in

United StatesCanadaBelgium

Round sizes

Series B $67M–$120M

Contacts

NameEmailPhoneSocials

Sign up to unlock verified contacts

Unlock Contacts

Round size

Series B
$67M–$120M

Investment Focus

Industry

  • Biotechnology 3 (75%)
  • Biopharma 2 (50%)
  • Health Care 2 (50%)
  • Life Science 2 (50%)
  • Medical 1 (25%)
See all 9 industries →

Stage

  • Series B 2 (50%)
  • Seed 1 (25%)
  • Series A 1 (25%)

Country

  • United States 2 (50%)
  • Canada 1 (25%)
  • Belgium 1 (25%)

Team

NameTitleInvestmentsLinksEmail
David Goodman
David Goodman Founder
Founder Total investments: 0 Find email

Investments

CompanyDescriptionRoundLinks
Coultreon Biopharma is developing best-in-class therapeutics that target clinically validated pathways in immunology and metabolic illnesses.Coultreon Biopharma employs extensive experience in disease biology, drug development, and translational science to identify the optimum treatment approach for addressing underlying illness biology withbest-in-class therapeutics. $125M / Series A / Apr 28, 2026
Triana Biomedicines Triana Biomedicines
Triana Biomedicines is building the leading molecular glue discovery platform to regulate disease targets that are difficult to address with any other modality. Triana’s drug discovery engine is powered by high- resolution structural insights, state-of-the-art in silico tools, and bespoke chemical libraries. The research team has validated thebest-in-class platform and initiated multiple programs across different disease areas. $120M / Series B / Dec 03, 2025
Cartography is shaping a world in which cancer immunotherapies are designed around and directed toward the safest and most effective targets. $67M / Series B / Oct 02, 2025
Reverb Therapeutics engages in the development of treatments for cancer and other diseases. $12M / Seed / Feb 19, 2025

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
EdTech
Venture Capital
Video Games
Hospitality
Restaurants
Crowdfunding
Financial Services
Photography
Cryptocurrency
Digital Media
Big Data
Email
Artificial Intelligence
Clean Energy
Non Profit
Social Impact
Energy
SaaS
Google
CleanTech
Consumer
Health Care
Enterprise Software
Local
Travel
Platforms
InsurTech
Construction
Oil and Gas
Mobile
Retail
Film
Payments
Marketplace
Fitness
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Medical Device
Wellness
Education
Sports
Legal
Automotive
eSports
Biotechnology
Renewable Energy
Software
Facebook
Blockchain
Theatre
Medical
Web3
Recruiting
Beauty
Fashion
Infrastructure
Celebrity
Social
Food and Beverage
Life Science
Publishing
Wine and Spirits
Mobile Apps
Real Estate
Sporting Goods
Music
Art
Finance
Manufacturing
FinTech
Social Media
Franchise
Internet
Mobile Advertising
Android
Impact
Proptech
Hardware
Transportation
Biotech
Sustainability
Enterprise
Community
Cannabis
Media (Entertainment)
LGBT
Climate
Any country
Afghanistan
Greece
Thailand
United Arab Emirates
Andorra
Dominica
Japan
Brazil
Singapore
Burkina Faso
Africa
LATAM
Egypt
United Kingdom
Faroe Islands
South Korea
Hong Kong
Benin
Nigeria
Togo
Croatia
Gibraltar
Guinea
Kyrgyzstan
Norway
Haiti
Sudan
Malawi
Isle of Man
Iran
Madagascar
Lesotho
Russian Federation
Turkey
Liberia
Nepal
Pakistan
Mexico
Tajikistan
Sweden
Zambia
Romania
Oceania
Argentina
Tunisia
Oman
Taiwan
Zimbabwe
Puerto Rico
Poland
Guernsey
Cameroon
Colombia
Armenia
China
Costa Rica
Côte d'Ivoire
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Morocco
Australia
Jamaica
Sri Lanka
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Uruguay
Moldova
New Zealand
Seychelles
Botswana
Paraguay
France
South Africa
Denmark
Georgia
Ghana
Iraq
Philippines
Portugal
Sierra Leone
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Bangladesh
Cyprus
Barbados
Qatar
Belgium
Austria
Ethiopia
Azerbaijan
Jordan
Ecuador
Bahamas
Bahrain
Bulgaria
Jersey
Estonia
Bolivia
Belize
Algeria
Belarus
Hungary
Finland
Grenada
Israel
Honduras
Lithuania
Italy
Cambodia
Iceland
Liechtenstein
Lebanon
Mongolia
Slovenia
Peru
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Finchley Healthcare Ventures invest in?

Finchley Healthcare Ventures invests primarily in Biotechnology, Biopharma and Health Care startups, most often at Series B and Seed stage. Most of the 4 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What round sizes does Finchley Healthcare Ventures invest in?

Finchley Healthcare Ventures typically joins rounds of $67M–$120M at Series B. These are whole funding-round sizes, not Finchley Healthcare Ventures's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Finchley Healthcare Ventures took part in.

How do I contact Finchley Healthcare Ventures?

Public channels for Finchley Healthcare Ventures include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at Finchley Healthcare Ventures?

The team at Finchley Healthcare Ventures includes David Goodman (Founder). The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Nov 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Finchley Healthcare Ventures Finchley Healthcare Ventures Find emails